New
TVM Capital
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
TVM Capital is a global venture and growth capital firm that aims to finance select biopharmaceutical and medical device companies.
HQ Location
Germany
Founded
1983
Employees
11 - 50
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Operator of an investment platform intended to invest in promising entrepreneurs, the development of exciting life science products, and the growth of substantial companies. The company's platform focuses on a dedicated investment approach to develop early-stage pharmaceutical assets in a capital-efficient fashion, to a human proof-of-concept in single-asset companies and actively seeking investments in innovative later-stage biopharma, diagnostic, MedTech, and digital-health companies, helping companies and entrepreneurs with their development and growth.